NCT07180368Recruiting
Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
Source: ClinicalTrials.gov · Last updated 18 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this observational study is to understand the impact of polypharmacy on the prognosis of elderly patients with chronic diseases. The main research question it aims to address is: Does polypharmacy affect the prognosis of elderly patients with chronic diseases? Elderly patients with chronic diseases will be asked to complete online survey questions regarding their disease prognosis over a 2-year period.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 29 Jun 2025
- Start date
- Oct 2024
- Primary completion date
- Sept 2026
- Lead sponsor
- Xijing Hospital
- Diseases
- Chronic kidney disease, Heart failure, Obesity, Coronary artery disease, Stroke, COPD, High blood pressure
- NCT number
- NCT07180368
What you commit to
- Study type: Observational
- Planned participants: 2000
- From Oct 2024 to the primary completion date, Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients without chronic diseases
Other
- Patients refused to participate in the study
- Patients with unstable vital signs
Who the study is looking for
- Patients aged 65 years or older with at least one chronic disease
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xijing hospital Coordinator of this site? Confirm its status | Xi'an | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.